JCI SJR and Scopus Metrics: What the Numbers Actually Tell Authors
JCI's Scopus profile confirms that it still sits in the upper tier of translational medicine journals. The useful question is whether your paper truly bridges mechanism and human disease.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: The Journal of Clinical Investigation remains a high-end translational medicine journal under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 4.721, a CiteScore of 19.6, and Q1 standing in the research-and-experimental-medicine lane. That confirms real authority, but the submission decision still depends on whether the manuscript genuinely bridges mechanism and human disease rather than leaning too basic or too clinical.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 4.721 | Prestige-weighted influence remains strong |
CiteScore | 19.6 | Four-year citation performance is durable |
Quartile | Q1 | The journal remains top-tier in Scopus classification |
H-index | 558 | Long-run citation durability is substantial |
JCR context | Impact factor 13.6 | Web of Science tells the same upper-tier translational story |
The useful reading is that JCI still matters because its translational identity holds up under both prestige-weighted and longer-window citation systems.
What the metrics actually help with
They help position JCI correctly:
- stronger than many disease-specific clinical journals on mechanism-plus-human relevance
- below the most extreme translational flagships like Nature Medicine on raw prestige density
- especially useful for papers that sit between disease mechanism and human biology
That is useful when the shortlist includes JCI, JEM, Nature Medicine, or a strong specialty journal.
What the metrics do not answer
They do not tell you:
- whether the human-disease bridge is convincing enough
- whether the work is too basic for JCI
- whether the study is too clinical and thin on mechanism
- whether another specialty venue is a more honest fit
Those are still the real submission questions.
Why the profile matters for authors
At this SJR level, JCI can be selective without needing general-medicine brand theatrics. The journal's profile reflects a specific editorial product:
- mechanism tied clearly to disease
- evidence that travels across specialties
- enough human relevance to matter beyond model systems
- papers other physician-scientists and translational teams keep citing
That is why the numbers are useful. They show JCI is still a serious destination for bench-to-bedside work, not just a historically respected title.
What should drive the submission decision instead
The better question is whether the manuscript is truly a JCI paper.
That is why the better next reads are:
- Is JCI a good journal?
- JCI submission guide
- JCI submission process
- JCI impact factor
If the disease link is thin or the mechanism is still incomplete, the metrics do not rescue the mismatch. They only explain why JCI can reject many respectable translational papers quickly.
Practical verdict
JCI has a strong Scopus profile and remains a real upper-tier translational venue. That makes it a sensible target when the manuscript truly joins mechanism and human disease in a way other specialties will still care about.
But the useful takeaway is still fit, not reassurance. If the bridge between biology and patients is weak, the metric is already warning you. A free Manusights scan is the fastest way to pressure-test that before submission.
- JCI submission guide, Manusights.
Sources
- 1. The Journal of Clinical Investigation journal browser entry, Vrije Universiteit journal publishing guide.
- 2. JCI website, American Society for Clinical Investigation.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.